Vasectomy and risk for prostate cancer (all over again)

As long-term readers will be aware, this is a topic that comes up over and over again … about every couple of years … READ MORE …

The absolute increase in risk of prostate cancer after a vasectomy

Late last week we commented briefly on a paper by Siddiqui et al. that had assessed the association between risk for a diagnosis of prostate cancer and the prior occurrence of a vasectomy in men who participated in the Health Professionals Follow-up Study (HPFS). … READ MORE …

Vasectomy and prostate cancer — the debate evolves

As regular readers will be well aware, the question of whether there is a real cause and effect association between having a vasectomy and the later risk for diagnosis of prostate cancer is controversial and unanswered in any absolute sense. However, there are new data that we can now put on the table … … READ MORE …

Vasectomy and risk for prostate cancer all over again

Over the years there has been controversy as to the existence of an association between vasectomy and risk for prostate cancer. A new set of data from a large, long-term study, to be presented at the upcoming annual meeting of the American Society of Clinical Oncology, has shown that there is, indeed, such a risk — but it is specific to high-risk prostate cancer. … READ MORE …

Prostate cancer news reports: Saturday, May 9, 2009

This morning’s news reports discuss:

  • Vasectomy and prostate cancer
  • Preservation of erectile function during radical prostatectomy
  • Interferon-alfa as a treatment for localized prostate cancer
  • Immunotherapeutic agents in treatment of prostate cancer … READ MORE …

Thursday news update, Part A: October 30, 2008

There’s a lot of news today, so we will break it into two sections for reading convenience. In Part A, we deal with information about:

  • Physicial activity and prostate cancer risk
  • Vasectomy and prostate cancer risk
  • The use of surveillance and watchful waiting in men in Sweden
  • A modification to Walsh’s nerve-sparing radical prostatectomy
  • The risks of “multimodal” therapy in high-risk patients and
  • A new, long-acting form of testosterone therapy … READ MORE …